UPMC MCKEESPORT — History
CCN 390002 | 3-year financial timeline | COVID resilience: 32/100
🛡️ Public data only — no PHI permitted on this instance.
$122M
Latest Revenue (FY2022)
-0.5%
Revenue CAGR (3yr)
-39.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $123M | $131M | $122M | -7.1% | -0.5% |
| Operating Expenses | $155M | $166M | $170M | +2.8% | +4.8% |
| Operating Margin | -25.8% | -26.2% | -39.6% | -51.3% | +0.0% |
| Net Income | $-32M | $-34M | $-48M | -40.6% | +0.0% |
| Licensed Beds | 186 | 186 | 186 | +0.0% | +0.0% |
| Total Patient Days | 37,803 | 35,460 | 30,882 | -12.9% | -9.6% |
| Medicare Day % | 14% | 11% | 11% | -3.3% | -12.6% |
| Medicaid Day % | 2% | 1% | 1% | -9.8% | -13.7% |
COVID Impact & Recovery
Resilience Score: 32/100 — Distressed — significant COVID damage
Revenue recovery from FY2020 to FY2022: -1.0% ($123M → $122M)
FY2020 captured the initial COVID shock. Slow recovery suggests structural challenges beyond COVID.
Trend Summary
Revenue▶ Stable
Operating Margin▼ Declining
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
-0.5%
This Hospital
+7.6%
State Avg
Latest Margin
-39.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $121M | -46.5% |
| FY2024 (proj) | $121M | -53.4% |
| FY2025 (proj) | $120M | -60.3% |